AtriCure, Inc. (ATRC) Posts Q3 EPS Loss of $0.07
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $58.97 -0.56%
EPS Growth %: -300.0%
Financial Fact:
Other: -32K
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
EPS Growth %: -300.0%
Financial Fact:
Other: -32K
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
AtriCure, Inc. (NASDAQ: ATRC) reported Q3 EPS of ($0.07), $0.01 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $15.2 million versus the consensus estimate of $15.88 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AtriCure Inc. (ATRC) PT Raised to $68 at Citizens on Upside to Current Forecasts
- Gorman-Rupp (GRC) Tops Q3 EPS by 16c, Beats on Revenue
- Tompkins Financial (TMP) Tops Q3 EPS by 5c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
